Literature DB >> 27942860

Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer.

Weiwei Liang1, Zhiwei Xie2, Weiling Cui1, Yan Guo1, Lijuan Xu1, Jueheng Wu3, Hongyu Guan4.   

Abstract

PURPOSE: The oncogenic roles of sphingosine kinase 1 (SphK1) in various cancers, including thyroid cancer, have been well demonstrated. However, the microRNAs (miRNAs) associated with the oncogenic roles of SphK1 remain largely unknown.
METHODS: Global gene and miRNA expression in TPC1-Vector and TPC1-SphK1 cells was analyzed using digital gene expression (DGE) analysis and small RNA-seq, respectively. miRNA-mRNA interactions were explored by microT-CDS, and the predicted networks were visualized using CytoScape®. Cell invasion and migration were assessed by performing Transwell invasion and wound-healing assays. Luciferase reporter and immunoblot assays were used to evaluate the targeting of fibronectin 1 (FN1) by miR-144-3p.
RESULTS: In this study, we found that overexpression of SphK1 differentially regulates the expression of 46 miRNAs and 506 mRNAs in papillary thyroid cancer (PTC) TPC1 cells. Combining bioinformatics predictions of mRNA targets with DGE data on mRNA expression allowed us to identify the mRNA targets of deregulated miRNAs. The direct interaction between miR-144-3p and FN1, which mediates the pro-invasive role of SphK1 in PTC cells, was experimentally validated.
CONCLUSIONS: Our results demonstrated that SphK1 overexpression drives a regulatory network governing miRNA and mRNA expression in PTC cells. We also demonstrated the roles played by miR-144-3p and FN1 in mediating the oncogenic function of SphK1, which enhanced the understanding of the etiology of PTC.

Entities:  

Keywords:  FN1; Invasion; Papillary thyroid cancer; SphK1; miR-144-3p

Mesh:

Substances:

Year:  2016        PMID: 27942860     DOI: 10.1007/s00432-016-2315-0

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  39 in total

1.  Gene expression in papillary thyroid carcinoma reveals highly consistent profiles.

Authors:  Y Huang; M Prasad; W J Lemon; H Hampel; F A Wright; K Kornacker; V LiVolsi; W Frankel; R T Kloos; C Eng; N S Pellegata; A de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Inhibition of SPHK1 suppresses phorbol 12-myristate 13-acetate-induced metastatic phenotype in colorectal cancer HT-29 cells.

Authors:  Meng-Bin Qin; Jie-An Huang; Shi-Quan Liu; Guo-Du Tang; Hai-Xing Jiang
Journal:  Oncol Res       Date:  2011       Impact factor: 5.574

3.  Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells.

Authors:  Marialuisa Sponziello; Francesca Rosignolo; Marilena Celano; Valentina Maggisano; Valeria Pecce; Roberta Francesca De Rose; Giovanni Enrico Lombardo; Cosimo Durante; Sebastiano Filetti; Giuseppe Damante; Diego Russo; Stefania Bulotta
Journal:  Mol Cell Endocrinol       Date:  2016-05-10       Impact factor: 4.102

4.  Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2.

Authors:  Hongyu Guan; Weiwei Liang; Zhiwei Xie; Hai Li; Juan Liu; Liehua Liu; Lingling Xiu; Yanbing Li
Journal:  Endocrine       Date:  2014-06-27       Impact factor: 3.633

5.  Fibronectin 1 protein expression in clear cell renal cell carcinoma.

Authors:  S Steffens; A J Schrader; Gesa Vetter; H Eggers; H Blasig; J Becker; M A Kuczyk; J Serth
Journal:  Oncol Lett       Date:  2012-01-12       Impact factor: 2.967

6.  SOX2 targets fibronectin 1 to promote cell migration and invasion in ovarian cancer: new molecular leads for therapeutic intervention.

Authors:  Xiaoyan Lou; Xu Han; Chengmeng Jin; Wei Tian; Wei Yu; Dong Ding; Lihua Cheng; Bingding Huang; Huawei Jiang; Biaoyang Lin
Journal:  OMICS       Date:  2013-07-29

7.  High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation.

Authors:  Yukihiro Akao; Yoshiko Banno; Yoshihito Nakagawa; Nobuko Hasegawa; Tack-Joong Kim; Takashi Murate; Yasuyuki Igarashi; Yoshinori Nozawa
Journal:  Biochem Biophys Res Commun       Date:  2006-02-21       Impact factor: 3.575

8.  In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma.

Authors:  Michal Swierniak; Anna Wojcicka; Malgorzata Czetwertynska; Elzbieta Stachlewska; Monika Maciag; Wieslaw Wiechno; Barbara Gornicka; Magdalena Bogdanska; Lukasz Koperski; Albert de la Chapelle; Krystian Jazdzewski
Journal:  J Clin Endocrinol Metab       Date:  2013-06-19       Impact factor: 5.958

9.  SPHK1 regulates proliferation and survival responses in triple-negative breast cancer.

Authors:  Arpita Datta; Ser Yue Loo; Baohua Huang; Lingkai Wong; Sheryl S L Tan; Tuan Zea Tan; Soo-Chin Lee; Jean Paul Thiery; Yaw Chyn Lim; Wei Peng Yong; Yulin Lam; Alan Prem Kumar; Celestial T Yap
Journal:  Oncotarget       Date:  2014-08-15

10.  MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2.

Authors:  Ying Shao; Peng Li; Sheng-Tao Zhu; Ji-Ping Yue; Xiao-Jun Ji; Dan Ma; Li Wang; Yong-Jun Wang; Ye Zong; Yong-Dong Wu; Shu-Tian Zhang
Journal:  Oncotarget       Date:  2016-03-22
View more
  5 in total

1.  SPHK1 promotes metastasis of thyroid carcinoma through activation of the S1P/S1PR3/Notch signaling pathway.

Authors:  Zhijing Zhao; Junfeng Ma; Baoquan Hu; Yi Zhang; Shushu Wang
Journal:  Exp Ther Med       Date:  2018-04-12       Impact factor: 2.447

2.  Circulating Exosomal miR-144-3p from Crohn's Disease Patients Inhibits Human Umbilical Vein Endothelial Cell Function by Targeting FN1.

Authors:  Peng Qu; Xiaoran Xie; Jingshu Chi; Xiaoming Liu; Peng Liu; Ju Luo; Huan Li; Sha Cheng; Xiujuan Xia; Xiong Chen; Canxia Xu
Journal:  Dis Markers       Date:  2022-06-02       Impact factor: 3.464

Review 3.  Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer.

Authors:  Guangmeng Xu; Zecheng Yang; Yamin Sun; Hongmei Dong; Jingru Ma
Journal:  Discov Oncol       Date:  2021-09-20

Review 4.  MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment.

Authors:  Maria Papaioannou; Angeliki G Chorti; Anthoula Chatzikyriakidou; Kleanthis Giannoulis; Sohail Bakkar; Theodosios S Papavramidis
Journal:  Front Oncol       Date:  2022-02-03       Impact factor: 6.244

5.  Sphingosine kinase 1 promotes tumor immune evasion by regulating the MTA3-PD-L1 axis.

Authors:  Poyee Lau; Guanxiong Zhang; Shuang Zhao; Long Liang; Hailun Zhang; Guowei Zhou; Mien-Chie Hung; Xiang Chen; Hong Liu
Journal:  Cell Mol Immunol       Date:  2022-09-01       Impact factor: 22.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.